Cargando…
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
A physiologically based pharmacokinetic (PBPK) model was developed that provides a comprehensive description of the kinetics of trichloroethylene (TCE) and its metabolites, trichloroethanol (TCOH), trichloroacetic acid (TCA), and dichloroacetic acid (DCA), in the mouse, rat, and human for both oral...
Autores principales: | Clewell, H J, Gentry, P R, Covington, T R, Gearhart, J M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637761/ https://www.ncbi.nlm.nih.gov/pubmed/10807559 |
Ejemplares similares
-
Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
por: Fisher, J W
Publicado: (2000) -
Issues in the Pharmacokinetics of Trichloroethylene and Its Metabolites
por: Chiu, Weihsueh A., et al.
Publicado: (2006) -
Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.
por: Moore, M M, et al.
Publicado: (2000) -
Physiologically Based Pharmacokinetic (PBPK) Modeling of Interstrain Variability in Trichloroethylene Metabolism in the Mouse
por: Chiu, Weihsueh A., et al.
Publicado: (2014) -
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.
por: Barton, H A, et al.
Publicado: (2000)